Vice President, Marketing, Neuroimmunology
Annexon Biosciences
Vice President, Marketing, Neuroimmunology
Annexon Biosciences
Develops C1q inhibitor therapies
Company:
At Annexon Biosciences we are a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases of the body, brain, and eye. Our novel scientific approach targets upstream C1q to block the classical complement inflammatory cascade before it starts, and its therapeutic candidates are designed to provide meaningful benefits across multiple autoimmune, neurodegenerative and ophthalmic diseases. With proof-of concept data in Guillain-Barré syndrome, Huntington’s disease and geographic atrophy, we are rigorously advancing our mid-to late-stage clinical trials to bring new potential treatments to patients as quickly as possible. At Annexon, you’ll be part of a team committed to making an impact together.
For more information on Annexon and our pipeline, check out our site Annexon Biosciences & Annexon Pipeline. We trade on Nasdaq under the ticker symbol ANNX and are headquartered in Brisbane, CA.
We're seeking exceptional talent from all backgrounds to fuel our growth. At Annexon, we're building a diverse, equitable, and inclusive workplace. We value unique perspectives and unconventional paths. If you're the best candidate for the job, even if you don't perfectly fit the traditional mold, we encourage you to apply. Learn more about our commitment to diversity, equity, inclusion, and our company culture!
Position:
We are seeking an accomplished Vice President, Marketing, Neuroimmunology to lead the commercial strategy and marketing execution for our Neuroimmunology portfolio. This individual will be a critical member of the Commercial Leadership Team, responsible for translating differentiated science and meaningful patient benefits into a compelling commercial strategy and exceptional launch execution. The VP will lead positioning, segmentation, customer strategy, launch planning, HCP engagement, omnichannel execution, and market development while partnering closely with Sales, Market Access, Medical Affairs, Patient Services, Analytics, Finance, and Corporate Communications.
The ideal candidate combines strategic sophistication with a hands-on operating mindset. They will be equally comfortable defining the long-term market-shaping strategy, presenting to senior leadership, engaging external experts, and working directly with cross-functional teams to ensure executional readiness.
Responsibilities include:
Commercial & Brand Strategy
Launch Leadership
HCP & Customer Engagement
Market Development
Insights, Analytics & Performance
Leadership & Organizational Development
Education, Experience, and Skills:
Required:
Preferred:
Salary Range: $317,600 - $353,000
Location: Annexon Biosciences is located in Brisbane, California and preference is given to candidates in the San Francisco Bay Area.
Benefits:
Annexon Biosciences is an Equal Opportunity Employer, and we prohibit discrimination or harassment of any kind. We are committed to fostering an environment where ALL people are welcome and supported. We cultivate a culture of inclusion for all employees that respects their individual strengths, views, and experiences. We believe that our differences enable us to be a better team – one that makes better decisions, drives innovation, and delivers better business results. Creativity and innovation flourish in an environment of openness, inclusion, and mutual respect.
Develops C1q inhibitor therapies
Annexon Biosciences develops therapies that target the classical complement pathway to treat autoimmune and neurodegenerative diseases, including eye conditions. Its main strategy is to inhibit C1q, the molecule that starts the complement cascade, with the aim of stopping disease progression at its source. The company advances therapies through clinical trials and may either commercialize them or partner with larger pharma firms to bring them to market. Revenue potential comes from product sales, licensing, and milestone payments from collaborations. Annexon’s goal is to deliver first-in-class C1q inhibitors that prevent tissue damage across diseases such as Alzheimer's, Huntington's, glaucoma, and related disorders, supported by substantial financing to push its pipeline forward.
Explore more opportunities at Annexon Biosciences